Source: Eur Respir J, 54 (2) 1801809; 10.1183/13993003.01809-2018
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Prasad Nagakumar, Franz Puttur, Lisa G. Gregory, Laura Denney, Louise Fleming, Andrew Bush, Clare M. Lloyd, Sejal Saglani. Pulmonary type-2 innate lymphoid cells in paediatric severe asthma: phenotype and response to steroids. Eur Respir J, 54 (2) 1801809; 10.1183/13993003.01809-2018

Member's Comments

No comment yet.

Related content which might interest you: Type two innate lymphoid cells (ILC2s) in the blood of children with acute asthma Source: International Congress 2017 – Diagnostic tools in paediatric asthma Year: 2017 Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: the role of thymic stromal lymphopoietin Source: International Congress 2018 – Roles of innate lymphoid cells in asthma Year: 2018 Role of innate lymphoid cells and the epithelium in asthma and bronchoconstriction Source: International Congress 2018 – It's my favourite cell that affects your asthma Year: 2018 Pulmonary dendritic cells from chronic obstructive pulmonary disease patients suppress lung immune responses through induction of regulatory T cells Source: Annual Congress 2011 - T-cell subsets Year: 2011 Rhinovirus induced innate immune responses in the epithelium of severe COPD Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD Year: 2019 Lymphoid follicles in (very) severe COPD: beneficial or harmful? Source: Eur Respir J 2009; 34: 219-230 Year: 2009 Assessment of innate immunity mediators in the lung of COPD patients: relation with disease manifestations Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity Year: 2020 Pulmonary and systemic cellular immune response network in patients with mild-moderate COPD Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017 Severe asthma: from inflammatory phenotype to treatment Source: International Congress 2017 – Chinese Programme 2017 Year: 2017 Anticholinergic treatment does not affect toll-like receptor 3-induced antiviral immune response in COPD bronchial epithelial cells Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Allergen-experienced group 2 innate lymphoid cells acquire memory-like properties and enhance allergic lung inflammation Source: International Congress 2018 – Roles of innate lymphoid cells in asthma Year: 2018 Dysregulation of type 2 innate lymphoid cells and Th2 cells impairs pollutant-induced allergic airway responses Source: International Congress 2016 – Immune responses in the lung Year: 2016 Innate lymphoid cells in isocyanate-induced asthma: role of microRNA-155 Source: Eur Respir J, 56 (3) 1901289; 10.1183/13993003.01289-2019 Year: 2020 The fraction of circulating type 2 innate lymphoid cells in peripheral blood is associated with asthma severity Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma Year: 2019 How cultured epithelial cells from asthma and COPD patients deal with pathogens: defective anti-rhinovirus responses in asthma Source: Research Seminar 2008 - Host-pathogen interactions in the lung: implications for treatment of respiratory infections and inflammatory lung diseases Year: 2008 Severe asthma in old patients is characterized by signs of immunosuppression and by lymphocyte resistance to glucocorticoids Source: Annual Congress 2012 - Aspects of clinical asthma Year: 2012 Profibrotic function of pulmonary group 2 innate lymphoid cells is controlled by regnase-1 Source: Eur Respir J, 57 (3) 2000018; 10.1183/13993003.00018-2020 Year: 2021 Evidence of a distinct phenotype of adult onset asthma characterized by an airway neutrophilia and poor response to inhaled corticosteroids Source: Eur Respir J 2001; 18: Suppl. 33, 21s Year: 2001